Inducible nitric oxide synthase: Regulation, structure, and inhibition

MA Cinelli, HT Do, GP Miley… - Medicinal research …, 2020 - Wiley Online Library
A considerable number of human diseases have an inflammatory component, and a key
mediator of immune activation and inflammation is inducible nitric oxide synthase (iNOS) …

Macrophage reprogramming and cancer therapeutics: role of iNOS-derived NO

K Kashfi, J Kannikal, N Nath - Cells, 2021 - mdpi.com
Nitric oxide and its production by iNOS is an established mechanism critical to tumor
promotion or suppression. Macrophages have important roles in immunity, development …

Arginase: a multifaceted enzyme important in health and disease

RW Caldwell, PC Rodriguez, HA Toque… - Physiological …, 2018 - journals.physiology.org
The arginase enzyme developed in early life forms and was maintained during evolution. As
the last step in the urea cycle, arginase cleaves l-arginine to form urea and l-ornithine. The …

Gasotransmitters in cancer: from pathophysiology to experimental therapy

C Szabo - Nature reviews Drug discovery, 2016 - nature.com
The three endogenous gaseous transmitters—nitric oxide (NO), carbon monoxide (CO) and
hydrogen sulfide (H2S)—regulate a number of key biological functions. Emerging data have …

Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies

F Hossain, AA Al-Khami, D Wyczechowska… - Cancer immunology …, 2015 - AACR
Myeloid-derived suppressor cells (MDSC) promote tumor growth by inhibiting T-cell
immunity and promoting malignant cell proliferation and migration. The therapeutic potential …

Arginine metabolism in myeloid cells shapes innate and adaptive immunity

PC Rodriguez, AC Ochoa, AA Al-Khami - Frontiers in immunology, 2017 - frontiersin.org
Arginine metabolism has been a key catabolic and anabolic process throughout the
evolution of the immune response. Accruing evidence indicates that arginine-catabolizing …

Role and therapeutic targeting of the PI3K/Akt/mTOR signaling pathway in skin cancer: a review of current status and future trends on natural and synthetic agents …

JC Chamcheu, T Roy, MB Uddin, S Banang-Mbeumi… - Cells, 2019 - mdpi.com
The mammalian or mechanistic target of rapamycin (mTOR) and associated phosphatidyl-
inositiol 3-kinase (PI3K)/protein kinase B (Akt) pathways regulate cell growth, differentiation …

The yin and yang of nitric oxide in cancer progression

AJ Burke, FJ Sullivan, FJ Giles, SA Glynn - Carcinogenesis, 2013 - academic.oup.com
Nitric oxide (NO) is a short-lived, pleiotropic molecule that affects numerous critical functions
in the body. Presently, there are markedly conflicting findings in the literature regarding NO …

Metabolic pathways of L-arginine and therapeutic consequences in tumors

J Szefel, A Danielak, WJ Kruszewski - Advances in medical sciences, 2019 - Elsevier
Difference in the metabolism of normal and cancer cells inspires to search for new, more
specific and less toxic therapies than those currently used. The development of tumors is …

Oxidative stress-related mechanisms in melanoma and in the acquired resistance to targeted therapies

S Pizzimenti, S Ribero, MA Cucci, M Grattarola… - Antioxidants, 2021 - mdpi.com
Melanoma is a highly aggressive cancer with the poorest prognosis, representing the
deadliest form of skin cancer. Activating mutations in BRAF are the most frequent genetic …